U.S. Markets closed

Shareholder suit against Pfizer to proceed, Bloomberg says

A lawsuit by shareholders against Pfizer (PFE) that alleges the company made misleading statements about Celebrex and Bextra is being allowed to proceed, according to a Bloomberg report that cites a decision by a U.S. District Court judge.